These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 18226741)
1. Interim monitoring of efficacy data is important and appropriate. Sydes MR; Parmar MK J Clin Epidemiol; 2008 Mar; 61(3):203-4. PubMed ID: 18226741 [No Abstract] [Full Text] [Related]
2. Monitoring clinical trials. Interim data should not be publicly available. Richards SM BMJ; 2001 Dec; 323(7326):1424. PubMed ID: 11778588 [No Abstract] [Full Text] [Related]
3. The independent statistician for data monitoring committees. DeMets DL; Fleming TR Stat Med; 2004 May; 23(10):1513-7. PubMed ID: 15122729 [TBL] [Abstract][Full Text] [Related]
4. Ethical issues arising when interim data in clinical trials is restricted to independent data monitoring committees. Wells RJ; Gartside PS; McHenry CL IRB; 2000 Jan; 22(1):7-11. PubMed ID: 12546010 [No Abstract] [Full Text] [Related]
5. Interim analysis in randomized trials: DAMOCLES' sword? Besselink MG; van der Graaf Y; Gooszen HG J Clin Epidemiol; 2010 Apr; 63(4):353-4. PubMed ID: 19959333 [No Abstract] [Full Text] [Related]
6. Randomized trials in oncology stopped early for benefit. Wilcox RA; Djulbegovic B; Moffitt HL; Guyatt GH; Montori VM J Clin Oncol; 2008 Jan; 26(1):18-9. PubMed ID: 18165635 [No Abstract] [Full Text] [Related]
7. Monitoring clinical trials. Several points are contentious. Parry D BMJ; 2001 Dec; 323(7326):1425. PubMed ID: 11778590 [No Abstract] [Full Text] [Related]
8. Current controversies in data monitoring for clinical trials. Pocock SJ Clin Trials; 2006; 3(6):513-21. PubMed ID: 17170035 [TBL] [Abstract][Full Text] [Related]
9. Monitoring clinical trials. Interim data are at least as important as interim analyses. Reidpath D BMJ; 2001 Dec; 323(7326):1425. PubMed ID: 11778591 [No Abstract] [Full Text] [Related]
10. Striding forward or getting too big for their boots? The developing role of data monitoring committees in clinical trials. Tharmanathan P; Calvert MJ; Freemantle N J Clin Pharm Ther; 2006 Apr; 31(2):111-8. PubMed ID: 16635044 [No Abstract] [Full Text] [Related]
11. Comments on 'maintaining confidentiality of interim data to enhance trial integrity and credibility' by TR Fleming et al. Korn EL; Hunsberger S; Freidlin B; Smith MA; Abrams JS Clin Trials; 2008; 5(4):364-5; author reply 365-6. PubMed ID: 18697851 [No Abstract] [Full Text] [Related]
12. Inadequate planning and reporting of adjudication committees in clinical trials: recommendation proposal. Dechartres A; Boutron I; Roy C; Ravaud P J Clin Epidemiol; 2009 Jul; 62(7):695-702. PubMed ID: 19135860 [TBL] [Abstract][Full Text] [Related]
13. Data monitoring (and safety) committees--what are they and why do we need them? Primary Care Alliance for Clinical Trials (PACT) Network. Pirotta M; Chondros P; Aust Fam Physician; 2004 Nov; 33(11):950-1, 956. PubMed ID: 15584339 [No Abstract] [Full Text] [Related]
14. [Monitoring the safety of participants in randomised clinical trials: basis and methods]. Tijssen JG Ned Tijdschr Geneeskd; 2008 Mar; 152(12):674-8. PubMed ID: 18438062 [TBL] [Abstract][Full Text] [Related]
15. More on data monitoring and large apparent treatment effects. Anderson JR Contemp Clin Trials; 2005 Jun; 26(3):416-7. PubMed ID: 15911475 [No Abstract] [Full Text] [Related]
16. The statistician and the data monitoring committee. D'Agostino RB Stat Med; 2004 May; 23(10):1501-2. PubMed ID: 15122726 [No Abstract] [Full Text] [Related]
17. Is it ethical to keep interim findings of randomised controlled trials confidential? Miller FG; Wendler D J Med Ethics; 2008 Mar; 34(3):198-201. PubMed ID: 18316463 [TBL] [Abstract][Full Text] [Related]
18. Monitoring clinical trials. Dissemination of decisions on interim analyses needs wider debate. Bird SM BMJ; 2001 Dec; 323(7326):1424. PubMed ID: 11744570 [No Abstract] [Full Text] [Related]